Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Wilkinson

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Cancer Treatment Reports|June 1, 1984
Etoposide infusions for treatment of metastatic lung cancerW P Steward, N Thatcher, J M Edmundson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distributionM J Lind, J M Margison, T Cerny, et al.
The Cancer Journal From Scientific American|November 1, 1995
Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancerR S Welch, R D James, P M Wilkinson, et al.
Clinical Endocrinology|October 1, 1985
Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasoneC G Beardwell, A C Hindley, P M Wilkinson, et al.
British Journal of Cancer|April 1, 1979
Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in manH H Wan, N Thatcher, P W Mullen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Clinical pharmacology of oral and intravenous 4-demethoxydaunorubicinD B Smith, J M Margison, S B Lucas, et al.
British Journal of Cancer|November 1, 1975
Granulocyte function in myeloblastic leukaemiaP M Wilkinson, C Sumner, I W Delamore, et al.
Surgical Oncology|February 1, 1992
Management of neutropenic colitisR Vohra, R J Prescott, S S Banerjee, et al.
Cancer Chemotherapy and Pharmacology|December 1, 1982
Tamoxifen (Nolvadex) therapy--radionale for loading dose followed by maintenance dose for patients with metastatic breast cancerP M Wilkinson, G G Ribiero, H K Adam, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1996
A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patientsP Bey, P M Wilkinson, M Resbeut, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Cancer Treatment Reports|June 1, 1984
Etoposide infusions for treatment of metastatic lung cancerW P Steward, N Thatcher, J M Edmundson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distributionM J Lind, J M Margison, T Cerny, et al.
The Cancer Journal From Scientific American|November 1, 1995
Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancerR S Welch, R D James, P M Wilkinson, et al.
Clinical Endocrinology|October 1, 1985
Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasoneC G Beardwell, A C Hindley, P M Wilkinson, et al.
British Journal of Cancer|April 1, 1979
Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in manH H Wan, N Thatcher, P W Mullen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Clinical pharmacology of oral and intravenous 4-demethoxydaunorubicinD B Smith, J M Margison, S B Lucas, et al.
British Journal of Cancer|November 1, 1975
Granulocyte function in myeloblastic leukaemiaP M Wilkinson, C Sumner, I W Delamore, et al.
Surgical Oncology|February 1, 1992
Management of neutropenic colitisR Vohra, R J Prescott, S S Banerjee, et al.
Cancer Chemotherapy and Pharmacology|December 1, 1982
Tamoxifen (Nolvadex) therapy--radionale for loading dose followed by maintenance dose for patients with metastatic breast cancerP M Wilkinson, G G Ribiero, H K Adam, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1996
A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patientsP Bey, P M Wilkinson, M Resbeut, et al.
Pageof 8